// App-Quantinova.ai

FRI0159 (2018) : Antibodies to post-translationally modified collagen ii in spondyloarthritis

Researchers

Presenter

  • C. Vinci

Principal Investigators

  • N/A

Medical Centers

  • Clinical Pharmacology Department, Queen Mary University of London, London, United Kingdom

  • Campus Bio-Medico, Rome, Italy

Locations

  • United Kingdom

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Dermatology

  • Musculoskeletal

Disease

  • Rheumatoid arthritis

  • Psoriatic arthritis

  • Spondyloarthritis

  • Fibromyalgia

  • Inflammatory Arthritis

  • Axial spondyloarthritis

Biomarkers

  • N/A

Drug/Treatment

  • ribose

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved